A new modified sunitinib schedule for metastatic renal cell cancer (mRCC): A pilot study.
Sebastiano Buti
No relevant relationships to disclose
Maddalena Donini
No relevant relationships to disclose
Silvia Lazzarelli
No relevant relationships to disclose
Matteo Brighenti
No relevant relationships to disclose
Rodolfo Passalacqua
No relevant relationships to disclose